We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DJD icon
10026
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$495M
$261K ﹤0.01%
+6,181
New +$278K
HY icon
10027
PUT
Hyster-Yale Materials Handling
HY
$618M
$261K ﹤0.01%
8,100
-27,500
-77% -$936K
TARK icon
10028
Tradr 2X Long Innovation ETF
TARK
$16.3M
$261K ﹤0.01%
+5,991
New +$317K
CBAY
10029
CALL
DELISTED
Cymabay Therapeutics
CBAY
$261K ﹤0.01%
88,400
+20,400
+30% +$48.7K
BCLI
10030
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$260K ﹤0.01%
6,287
+1,780
+39% +$80.2K
CNDT icon
10031
PUT
Conduent
CNDT
$236M
$260K ﹤0.01%
60,100
+39,500
+192% +$198K
EWH icon
10032
iShares MSCI Hong Kong ETF
EWH
$1.21B
$260K ﹤0.01%
11,711
-4,173
-26% -$90.5K
FMAY icon
10033
FT Vest US Equity Buffer ETF May
FMAY
$1.46B
$260K ﹤0.01%
7,578
-9,144
-55% -$328K
INSG icon
10034
CALL
Inseego
INSG
$77M
$260K ﹤0.01%
13,740
-4,990
-27% -$127K
PAYS icon
10035
PUT
Paysign
PAYS
$744M
$260K ﹤0.01%
171,300
-61,900
-27% -$102K
SPRY icon
10036
CALL
ARS Pharmaceuticals
SPRY
$562M
$260K ﹤0.01%
+61,300
New +$214K
EGIS
10037
DELISTED
2ndVote Society Defended ETF
EGIS
$260K ﹤0.01%
8,689
-2,769
-24% -$89K
AIV
10038
Aimco
AIV
$383M
$259K ﹤0.01%
40,573
-185,899
-82% -$1.17M
CKPT
10039
CALL
DELISTED
Checkpoint Therapeutics
CKPT
$259K ﹤0.01%
25,160
+19,870
+376% +$260K
COLL icon
10040
CALL
Collegium Pharmaceutical
COLL
$875M
$259K ﹤0.01%
14,600
-4,900
-25% -$82.4K
CWAN
10041
PUT
DELISTED
Clearwater Analytics
CWAN
$259K ﹤0.01%
+21,500
New +$348K
FLL icon
10042
CALL
Full House Resorts
FLL
$81.7M
$259K ﹤0.01%
42,600
+14,600
+52% +$113K
HIMS icon
10043
PUT
Hims & Hers Health
HIMS
$6.57B
$259K ﹤0.01%
57,100
-47,100
-45% -$201K
RCKT icon
10044
CALL
Rocket Pharmaceuticals
RCKT
$381M
$259K ﹤0.01%
+18,800
New +$224K
SCHH icon
10045
CALL
Schwab US REIT ETF
SCHH
$11.4B
$259K ﹤0.01%
12,300
-300
-2% -$6.9K
SPOK icon
10046
Spok Holdings
SPOK
$229M
$259K ﹤0.01%
41,217
+1,369
+3% +$9.96K
STC icon
10047
PUT
Stewart Information Services
STC
$2.08B
$259K ﹤0.01%
5,200
-1,000
-16% -$53.6K
SAFM
10048
PUT
DELISTED
Sanderson Farms Inc
SAFM
$259K ﹤0.01%
+1,200
New +$235K
ARDX icon
10049
Ardelyx
ARDX
$1.05B
$258K ﹤0.01%
+436,566
New +$322K
FPXE icon
10050
First Trust IPOX Europe Equity Opportunities ETF
FPXE
$5.15M
$258K ﹤0.01%
13,340
+747
+6% +$16.3K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.